Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany

The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant effect of the new medicines compared to an appropriate comparator as defined by the Federal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dabisch, Inna, Dethling, Jürgen, Dintsios, Charalabos-Markos, Drechsler, Melanie, Kalanovic, Daniel, Kaskel, Peter, Langer, Frank, Ruof, Jörg, Ruppert, Thorsten, Wirth, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: Springer 2014
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3901346/
https://ncbi.nlm.nih.gov/pubmed/24460706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-1991-4-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados